Your browser doesn't support javascript.
loading
ECCO essential requirements for quality cancer care: Melanoma.
Wouters, Michel W; Michielin, Olivier; Bastiaannet, Esther; Beishon, Marc; Catalano, Orlando; Del Marmol, Veronique; Delgado-Bolton, Roberto; Dendale, Rémi; Trill, Maria Die; Ferrari, Andrea; Forsea, Ana-Maria; Kreckel, Hannelore; Lövey, József; Luyten, Gre; Massi, Daniela; Mohr, Peter; Oberst, Simon; Pereira, Philippe; Prata, João Paulo Paiva; Rutkowski, Piotr; Saarto, Tiina; Sheth, Sapna; Spurrier-Bernard, Gilly; Vuoristo, Meri-Sisko; Costa, Alberto; Naredi, Peter.
Affiliation
  • Wouters MW; European Society of Surgical Oncology (ESSO); Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Michielin O; European Society for Medical Oncology (ESMO); Department of Oncology, CHUV, University Hospital of Lausanne, Lausanne, Switzerland.
  • Bastiaannet E; International Society of Geriatric Oncology (SIOG); Department of Surgery/Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands.
  • Beishon M; European School of Oncology (ESO), Milan, Italy.
  • Catalano O; European Society of Radiology (ESR); Department of Radiology, National Cancer Institute Fondazione Pascale, Naples, Italy.
  • Del Marmol V; Association of European Cancer Leagues (ECL); Euromelanoma, European Academy of Dermatology and Venereology (EADV); Department of Dermatology and Venereology, Erasme Hospital, ULB, Brussels, Belgium.
  • Delgado-Bolton R; European Association of Nuclear Medicine (EANM); Department of Diagnostic Imaging (Radiology) and Nuclear Medicine, San Pedro Hospital and Centre for Biomedical Research of La Rioja (CIBIR), University of La Rioja, Logroño, La Rioja, Spain.
  • Dendale R; European Society for Radiotherapy and Oncology (ESTRO); Radiation Oncology Department, Institut Curie, Paris, France.
  • Trill MD; International Psycho-Oncology Society (IPOS); ATRIUM: Psycho-Oncology & Clinical Psychology, Madrid, Spain.
  • Ferrari A; European Society for Paediatric Oncology (SIOPE); Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Forsea AM; European Association of Dermato Oncology (EADO); Dermatology Department, Elias University Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Kreckel H; European Society of Oncology Pharmacy (ESOP); Pharmacy Department, University Hospital Giessen and Marburg, Giessen, Germany.
  • Lövey J; Organisation of European Cancer Institutes (OECI); National Institute of Oncology, Budapest, Hungary.
  • Luyten G; Ocular Oncology Group (OOG); Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands.
  • Massi D; European Society of Pathology (ESP); Division of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy.
  • Mohr P; European Society of Skin Cancer Prevention (EUROSKIN); Elbe-Klinikum Buxtehude, Buxtehude, Germany.
  • Oberst S; Organisation of European Cancer Institutes (OECI); Cambridge Cancer Centre, Cambridge, UK.
  • Pereira P; Cardiovascular and Interventional Radiological Society of Europe (CIRSE); Clinic for Radiology, Minimally-Invasive Therapies and Nuclear Medicine, SLK-Clinics Heilbronn, Karl-Ruprecht-University of Heidelberg, Heilbronn, Germany.
  • Prata JPP; European Oncology Nursing Society (EONS); Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal.
  • Rutkowski P; European Organisation for Research and Treatment of Cancer (EORTC); Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland.
  • Saarto T; European Association for Palliative Care (EAPC); Comprehensive Cancer Center, Department of Palliative Care, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Sheth S; European CanCer Organisation, Brussels, Belgium.
  • Spurrier-Bernard G; European CanCer Organisation (ECCO) Patient Advisory Committee; Melanoma Patient Network Europe; Paris, France.
  • Vuoristo MS; Association of European Cancer Leagues (ECL); Pirkanmaa Cancer Society, Tampere, Finland.
  • Costa A; European School of Oncology (ESO), Milan, Italy.
  • Naredi P; European CanCer Organisation (ECCO); Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Electronic address: peter.naredi@gu.se.
Crit Rev Oncol Hematol ; 122: 164-178, 2018 Feb.
Article de En | MEDLINE | ID: mdl-29458785
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Prestations des soins de santé / Oncologie médicale / Mélanome Type d'étude: Guideline Aspects: Determinantes_sociais_saude Limites: Humans Pays/Région comme sujet: Europa Langue: En Journal: Crit Rev Oncol Hematol Sujet du journal: HEMATOLOGIA / NEOPLASIAS Année: 2018 Type de document: Article Pays d'affiliation: Pays-Bas Pays de publication: Pays-Bas
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Prestations des soins de santé / Oncologie médicale / Mélanome Type d'étude: Guideline Aspects: Determinantes_sociais_saude Limites: Humans Pays/Région comme sujet: Europa Langue: En Journal: Crit Rev Oncol Hematol Sujet du journal: HEMATOLOGIA / NEOPLASIAS Année: 2018 Type de document: Article Pays d'affiliation: Pays-Bas Pays de publication: Pays-Bas